Literature DB >> 24025526

Hemosiderotic fibrolipomatous tumor, not an entirely benign entity.

David A Solomon1, Cristina R Antonescu, Thomas M Link, Richard J O'Donnell, Andrew L Folpe, Andrew E Horvai.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24025526     DOI： 10.1097/PAS.0b013e31829ff078

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN： 0147-5185            Impact factor:   6.394


× No keyword cloud information.
  3 in total

1.  Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.

Authors:  Yu-Chien Kao; Valentina Ranucci; Lei Zhang; Yun-Shao Sung; Edward A Athanasian; David Swanson; Brendan C Dickson; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2017-11       Impact factor: 6.394

2.  Radiological imaging features and clinicopathological correlation of hemosiderotic fibrolipomatous tumor: experience in a single tertiary cancer center.

Authors:  Dearbhail O'Driscoll; Edward Athanasian; Meera Hameed; Sinchun Hwang
Journal:  Skeletal Radiol       Date:  2014-12-21       Impact factor: 2.199

3.  Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot.

Authors:  Abbas Agaimy; Norbert Meidenbauer; William R Sukov; Robert Stoehr; Michael Vieth; Frank Roemer; Robert Grützmann; Andrew L Folpe
Journal:  Virchows Arch       Date:  2021-08-14       Impact factor: 4.064
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.